Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?

Lippi Giuseppe; Henry Brandon M.; Pighi Laura; De Nitto Simone; Salvagno Gian Luca

doi:10.1515/almed-2023-0008

Advances in Laboratory Medicine (Mar 2023)

Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?

Lippi Giuseppe,
Henry Brandon M.,
Pighi Laura,
De Nitto Simone,
Salvagno Gian Luca

Affiliations

Lippi Giuseppe: Section of Clinical Biochemistry, University of Verona, Verona, Italy
Henry Brandon M.: Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Pighi Laura: Section of Clinical Biochemistry, University of Verona, Verona, Italy
De Nitto Simone: Section of Clinical Biochemistry, University of Verona, Verona, Italy
Salvagno Gian Luca: Section of Clinical Biochemistry, University of Verona, Verona, Italy

DOI: https://doi.org/10.1515/almed-2023-0008
Journal volume & issue: Vol. 4, no. 2
pp. 175 – 179

Abstract

Read online

We planned this study to verify whether immunoassays for quantifying anti-SARS-CoV-2 IgG/IgM antibodies against both spike (S) and nucleocapsid (N) proteins may be used for identifying previous SARS-CoV-2 infections.

Published in Advances in Laboratory Medicine

ISSN: 2628-491X (Online)
Publisher: De Gruyter
Country of publisher: Germany
LCC subjects: Medicine: Medicine (General): Medical technology
Website: https://www.degruyter.com/journal/key/almed/html

About the journal

Abstract

Keywords